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SUMMARY
In South Brazil the circulation of two HIV-1 subtypes with different characteristics represents an important scenario for the 
study of the impact of HIV-1 diversity on the evolution of the HIV-1 epidemic and AIDS disease. HIV-1 B, the predominant variant 
in industrialized countries and HIV-1 C, the most prevalent subtype in areas with rapid epidemic growth, are implicated in most 
infections. We evaluated blood samples from 128 antiretroviral (ARV) naïve patients recruited at entry to the largest HIV outpatient 
service in Porto Alegre. Based on partial pol region sequencing, HIV-1 C was observed in 29%, HIV-1 B in 22.6% and, the recently 
identified CRF31_BC, in 23.4% of 128 volunteers. Other variants were HIV-1 F in 10% and other mosaics in 5.5%. In order to 
evaluate the association of socio-behavioral characteristics and HIV-1 subtypes, interviews and laboratory evaluation were performed 
at entry. Our data suggest an established epidemic of the three major variants, without any evidence of partitioning in either of the 
subgroups analyzed. However, anal sex practices were associated with subtype B, which could indicate a greater transmissibility of 
non-B variants by vaginal intercourse. This study provides baseline information for epidemiologic surveillance of the changes of the 
molecular characteristics of HIV-1 epidemics in this region.
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INTRODUCTION
It is estimated that over 33.2 million individuals are currently living 
with HIV/AIDS worldwide, 1.6 million in Latin America11. From 1980 
to June 2007, 474,273 AIDS cases were identified in Brazil, 89,250 in 
the South region, with almost 43,388 in Rio Grande do Sul (RS)2. 
A better knowledge of the genetic variability of the human 
immunodeficiency virus type I (HIV-1) can be crucial to the development 
of vaccine products and antiretroviral therapy. Worldwide, about 50% 
of HIV infections are caused by HIV-1 subtype (clade) C, whereas 
subtype B predominates in industrialized countries, corresponding to 
about 10% of all infections. HIV-1 clade B is observed in all countries 
in the Americas, including Brazil. Although the predominance of clade 
B has been demonstrated in studies conducted in different regions of the 
country, non-B variants and recombinant forms are not uncommom5,7,14,24. 
On the other hand, clade C predominates in south Brazil4,6,17. Recently a 
near full length sequencing of a new recombinant form, CRF31_BC, has 
been reported19. The information about the number of people living with 
HIV-1 CRF31_BC is limited, especially among new, ARV naïve HIV 
infected patients. Moreover, the association between socio-behavioral 
factors and the infection caused by HIV major circulating variants has 
not been clearly established. 
Our study aimed to evaluate the prevalence of the circulating 
recombinant form (CRF31_BC) in our population and to access the risk 
factors associated with the transmission of the major circulating variants 
among new, ARV naïve cases initiating follow up at our service, Serviço 
de Assistência Especializada em DST/AIDS, Prefeitura Municipal de 
Porto Alegre.
MATERIALS AND METHODS
This study was conducted at the Serviço de Assistência Especializada 
em DST/AIDS, the major unit dedicated to outpatient care of people 
with HIV/AIDS in Porto Alegre. The unit is part of the health system of 
the municipality of Porto Alegre (SAE/PMPA), the major metropolitan 
area in south Brazil. The service is located at Santa Tereza district, in 
the south of the city. By October 2008, about 8,000 patients with HIV/
AIDS, HTLV and/or STD had started a course of follow up treatment with 
the service. The majority of these patients live in the metropolitan area 
of Porto Alegre. Patients were invited to participate during the first visit 
to the clinic. After informed consent was signed, information on socio-
behavioral factors, clinical and laboratorial status were obtained, along 
with additional blood samples for HIV sequencing. All patients signed 
the informed consent and agreed to participate in this initial evaluation 
and to be part of a prospective cohort. The recruitment spanned from July 
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2004 to December 2005. The study was organized with the support of the 
Vaccine Initiative of the National AIDS Program, with the main objective 
being to implement a new HIV research site in the country. Due to the 
known co-circulation of different subtypes in the region, this initiative 
aimed to organize a small cohort in which physicians could evaluate the 
impact of HIV diversity in clinical evolution and ARV response. Two 
hundred and fifty three patients from the local voluntary counseling and 
testing site (VTC) and local public health network started follow up with 
our service during this period. The inclusion criteria were: age greater 
than 18 years, no previous exposure to ARV treatment, residence in the 
metropolitan area of Porto Alegre. Pregnant women were excluded. From 
the 253 patients, 17 were kept in follow up but excluded from the cohort 
at the second visit due to documented or potential use of ARV. Out of the 
remaining 236 patients, HIV sequencing was obtained from a random 
sampling of 128 individuals. Information was obtained from an individual 
questionnaire and data was collected by a trained research assistant. 
Clinical and laboratory data were obtained from patients’ clinical files. 
Blood samples were collected with EDTA (Becton- Dickinson, San 
Jose, CA, USA) and analyzed for TCD4 (Flow Cytometry, Becton- 
Dickinson, San Jose, CA, USA) and viral load quantification (bDNA, 
Bayer diagnostics, Germany) at the local municipal laboratory following 
manufacturers’ recommendation. Additional plasma was also collected 
with EDTA, separated by centrifugation and preserved at -70 °C until 
use. Biological material was transported in dry ice to Adolfo Lutz in São 
Paulo. Plasma was concentrated by centrifugation at 22,000 x g for 120 
min at 4 °C. Plasma HIV viral RNA was isolated using Trizol reagent 
(GIBCO-USA) or Qiamp® viral RNA mini kit (Quiagen, Germany) 
according to manufactures’ instructions. Complementary DNA synthesis 
was performed SuperScript III enzyme, (Life Technologies, USA) in a 
final volume of 20 mL, at 50 °C for 60 min. HIV-1 polymerase fragment 
spanning the entire protease gene (PR) and part of reverse trancriptase 
(RT, codons 1 to 235, relative to HXB2) were obtained by PCR as 
previously described3. Purified products were sequenced in an automated 
ABI 3100 Genetic Analyser (Applied Biosystems, USA). All sequencing 
chromatograms obtained were assembled with Sequencher 4.7 software 
and manually edited to identify mixtures. Automatic assembly (http://
www.ial.sp.gov.br/cgi-bin/HIV/submissao/ submissao.pl) was used to 
verify quality and obtain contigs for phylogenetic analysis. HIV-1 clade 
was screened using both National Center for Biotechnology Information 
- NCBI (www.ncbi.gov) and REGA HIV-1 Subtyping Tool (http://jose.
med.kuleuven.be) and further characterized by phylogenetic analysis as 
described below. Multiple alignments were performed using ClustalW 
multiple-sequence alignment software, with a reference set from the 
Los Alamos HIV-1 database (www.hiv.lanl.gov). Sequences were 
manually edited according to their codon-reading frame using BioEdit 
software. Neighbor Joining (NJ) and Maximum Likelihood (ML) trees 
were constructed based on appropriate nucleotide substitution models 
determined by Modeltest v3.7, tested with a hierarchical likelihood ratio 
test estimated under the HKY model, using PAUP (v4b10). Bootstrapping 
was performed using the stepwise addition algorithm for 1,000 replicates. 
Trees were visualized using the Tree View program. Sequences showing 
discordant PR/RT classification or outlier behavior on NJ trees or any 
non-B signal at the NCBI site (http://www.ncbi.nlm.nih.gov/projects/
genotyping/formpage.cgi) were selected for bootscanning analysis 
using SIMPLOT 2.5 to evaluate recombination breakpoints using HIV-1 
Consensus sequences. Breakpoints suggested at the bootscanning plot 
allowed the delimitation of fragments that were subjected to jump cluster 
analysis. NJ trees were constructed with fragments of the alignments 
to see if the query sequence jumps to the subtype cluster observed in 
the bootscanning plot. Further investigations on breakpoint positions 
were made by inspection of subtype nucleotide signatures. The clinical 
and behavioral data were organized with Epidata. Data were exported 
and final analysis was performed with the SPSS version 14.0 program. 
Categorical variables were initially described with absolute and relative 
frequencies. Quantitative variables were explored by mean and standard 
deviation when symmetrical (normal distribution) and with median and 
interquartil distribution whenever asymmetric. Categorical variables were 
analyzed using Qui-square or Exact Fisher tests and quantitative variables 
were compared among groups using Analysis of Variance (ANOVA) or 
Kruskal Wallis test whenever the distribution were asymmetric.
The assumed level of significance was 5%. The study was revised 
and approved by the Ethics Committee of the Health Secretary of Porto 
Alegre and of the Adolfo Lutz Institute. All patients signed informed 
consent when entering the study. The study was also approved by the 
National Ethics Committee (CONEP registry 9553, number 270/2004). 
The study was partially supported by the AIDS National Program 
(CFA 029/4 914BRA 3014 DST-AIDS II) and by the Municipal Health 
Department of Porto Alegre. 
RESULTS
The majority of the patients were adults at productive age, referring to 
themselves as white (European) ethnic background. Serologic diagnosis 
of HIV infection dated from January 1992 to July 2005, but, in most 
cases (74.2%) the diagnosis was made in 2004 or 2005. The male/female 
ratio was 1.3:1. Sexual exposure, as the unique risk factor for acquisition 
of HIV, was reported by most individuals (94.5%), with 87% of them 
reporting only heterosexual exposure. Exclusive vaginal intercourse was 
reported by (54.5%) and 40.8% of the individuals reported anal sex. 
HIV-1 subtype C was observed in 29% of the individuals, subtype 
B in 22.6%, CRF31_BC in 23.4%, F in 10% and other mosaics in 
5.5%. Molecular evaluation of these mosaics structures was described 
elsewhere3. 
Of the 24 individuals infected with HIV-1 B, 16 (66.7%) made 
reference to anal sex, 12 of these being male patients. Among the 28 
individuals infected with CRF31_BC, 14 were male and 14 were female. 
Twenty one of the individuals (75%) referred only to vaginal intercourse 
(with or without oral) practices. The occurrence of anal sex is significantly 
different when individuals infected with clade B are compared to CRF31_
BC (p = 0.01) and overall, the practice of anal sex was more common 
among individuals infected with clade B as compared to non-B (C or 
CRF31_BC) (p < 0.013). Among women, 28% mentioned the practice 
of anal sex. Exclusive vaginal/oral sex was referred to by most women 
infected with CRF31_BC (92.9%; 13 out of 14), whereas anal sex was 
reported in 50% (4/8 cases) of females infected with subtype B (p < 0.04).
Thirty five percent of the patients reported previous sexual exposure 
with a known HIV infected partner, 19.4% with an IDU partner, 12.6% 
with a male partner who had had sex with other men, 22.3% with sex 
workers and 25.2% with unknown partners. The consistent use of 
male condoms in all sexual intercourse was reported by 9.9%, 43.2% 
reported occasional use and 44.1% had never used condoms. Among 
the 68% of individuals that agreed to address drug relate issues, 11.5% 
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reported use of crack, 3.4% inhaled cocaine, 65.5% alcohol and 16.1% 
marijuana, with no differences among the HIV subtypes. Almost all 
individuals presented asymptomatic at first visit. The median CD4 
count at enrollment was 330.5 cells/mm3. No association with gender, 
ethnicity, sexual orientation, type of exposition, income, type of illicit 
drug, plasma viremia or TCD4 count at entry was observed. Table 1 
summarizes the socio-behavioral factors, laboratory and clinical stage 
Table 1
Social behavioral characteristics of the population (n = 128)**
N %
AGE (mean) 35.5
Gender
     Male 72 56.3
     Female 56 43.8
Race
     White 76 59.4
     Black 36 28.1
     Colored 15 11.7
     Other 1 0.8
Sexual orientation*
     Heterossexual 107 87
     Homossexual 9 7.3
     Bissexual 7 5.7
Type of exposure
     Sexual transmission 121 94.5
     Intravenous drug use 17 14
Years of formal study
     None 8 6.3
     From 1 to 3 years 23 18
     4 to 7 39 30.5
     8 to 11 46 35.9
     > 12 years 12 9.4
Monthly income* 
     No income 17 14
     Up to U$ 350 24 19.8
     U$ 350 - U$ 1,000 36 29.8
     Over U$ 1,000 44 36.4
WHO*
     I 88 72.7
     II 17 14
     III 12 9.9
     IV 4 3.3
CD4 at entry 330.5 (130.5; 462.25)
CV INITIAL 16.628.5 (3264.75; 52.294.75) 
4.21 (3.51;4.7)
Table 1 depicts socio-behavioral, laboratory and clinical data from studied 
volunteers. 
*Variables with missing data: income n = 121, sexual orientation = 123, WHO n = 
121; **Data is presented by total (percentage), CD4 initial - median, (interquartil 
interval), CV initial - median (interquartil interval); log mean ± standard deviation.
Table 2
HIV-1 clade at pol (n = 128)
 
Viral clade at pol N %
C 37 29
CRF31_BC 30 23.4
B 29 22.6
F 13 10.1
B_* 7 5.5
C_* 5 3.9
BC mosaics** 3 2.3
BF mosaics 2 1.6
CF mosaics 2 1.6
TOTAL 128 100
Table 2 describes viral subtypes or mosaics isolated from study participants. 
*Samples with sequence from only protease or RT region; **All other BC mosaics 
with recombinant structure distinct from CRF31_BC.
Table 3
Sexual practice and HIV-1 subtype
Vaginal (+/- oral) 
exclusive n (%)
Anal   n (%)
Males Females Males       Females
HIV-1 B 4 (25)   4 (50) 12 (75)     4 (50)
HIV-1 C 6 (50)         9 (64.3)   6 (50)     5 (35.7)
CRF31_BC 8 (57.1)    13 (92.9)   6 (42.9)  1 (7.1)
Table 3 shows the absolute number (percentage) of cases relating either exclusive 
vaginal sexual intercourse (with or without oral sex) or those relating also anal 
sex according to gender, by HIV-1 subtype. 
Practice of anal sex was more common among individuals infected with clade B 
as compared to non-B (C or CRF31_BC) (p < 0.013). The occurrence of anal sex 
is significantly different when individuals infected with clade B are compared to 
CRF31_BC (p = 0.01). Among women, exclusive vaginal/oral sex is significantly 
more common among females infected with CRF31_BC as compared to females 
infected with  HIV-1 B (p < 0.04).
(WHO classification) of this population (n =128). Table 2 describes viral 
subtypes or mosaics isolated from the blood samples of the participants. 
Table 3 shows sexual practices according to HIV-1 subtypes. Table 4 
describes the different aspects evaluated according to HIV subtyping 
assignment. More detailed molecular characterization of these samples 
was recently published3. Sequences used in this work are available at 
Genbank, accession numbers: EF 379156-71; EF 393720-22; EF 393725-
51; EF 393759-810; EF 393846-48; EF 393851-75; EF 393892-940.
DISCUSSION
South Brazil had, in 2006, an incidence of 17 AIDS cases/100,000 
inhabitants, with 21.2 in RS State2. At the municipality, with 1,420,667 
inhabitants10, there was an AIDS prevalence rate of 76/100,000 in 2006, 
somewhat higher than that observed in 2005, (75.1 cases per 100,000 
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inhabitants)22. From 1983 to 2006, 15,301 cases were reported in Porto 
Alegre, a cumulative prevalence of 587 cases/100,000 inhabitants. 
No major changes in the risk factor profile of the epidemic have been 
observed in the last decade, with a predominance of heterosexual behavior 
(60.4%), followed by intravenous drug usage (IDU) (16.1%) and homo/
bisexual (13%) behavior. IDU is considered a major factor in HIV 
dissemination and the city has the highest proportion of IDU related cases 
in the country22. The influence of these factors are expected to change 
with the evolution of the epidemic over time, and, as has been observed 
in other areas of Brazil, our newly identified HIV infected patients 
report a predominance of heterosexual behavior with low frequency of 
IDU related cases. Another aspect related to the current AIDS data is 
the increasing proportion of cases among women. In Brazil the male/
female ratio is changing, from 15:1 in 1986 to 1.5:1 in 20052. Our study 
shows a higher proportion of females among these new cases. Regarding 
the risk factors for HIV acquisition, throughout the period of 1980 to 
2007, a tendency has been observed towards the increasing proportion 
of heterosexual exposure, stabilization among homo/bisexuals and 
the reduction of UDI. Molecular characteristics have been associated 
with differences in epidemic potential, and in regions where HIV-1 
C dominates, as in the countries in the south of Africa, the epidemic 
has grown at rates greater than that observed in areas dominated by 
other HIV variants9. If we take into account that the recombinant form 
CRF31_BC is made up of an almost entire C genome, with a small portion 
of clade B genome in the RT region, and the sum of clades C (29%) and 
the CRF31_BC (23.4%) at the analyzed polymerase region, HIV-1 C 
genomes constitute the majority of the infections in our cohort. This has 
been documented in other areas of the south of Brazil, especially in cities 
that report the highest incidence of AIDS cases in our country3. The fact 
that the CRF31_BC has been detected in such a large proportion in our 
Table 4
Patient characteristics according to clade (B, C and CRF31_BC)
Characteristics B  
n = 29(%)
 C  
n = 37(%)
CRF31_BC  
n = 30 (%)
p
Male gender 20 (69) 20 (54.1) 16 (53.3) 0.380
Race*
     White 19 (65.5) 17 (45.9) 18 (62.1) 0.53
     Black 7 (24.1) 14 (37.8) 8 (27.6) 0.553
     Colored 3 (10.3) 6 (16.2) 3 (10.3) 0.553
Sexual behavior*
     Heterossexual 21 (75) 29 (87.9) 27 (90.0) 0.356
     Homossexual 5 (17.9) 2 (6.1) 1 (3.3) 0.356
     Bissexual 2 (7.1) 2 (6.1) 2 (6.7) 0.356
Risk factor
     Sexual 28 (96.5) 32 (86.4) 30 (100) 1.0
     UDI 3 (10.7) 7 (2.9) 2 (6.7) 0.188
Monthly income*
     Up to U$ 350 8 (30.8) 12 (35.3) 13 (43.3) 0.144
     U$350 to - U$1,000 4 (15.4) 13 (38.2) 9 (26.5) 0.144
     Over U$ 1,000 13 (43.3) 7 (23.3) 10 (33.3) 0.144
Type of drugs*
     Alcohol 14 (66.7) 13 (56.5) 15 (75) 0.442
     Cocaine 0 0 1 (5) 0.327
     Crack 0 3 (13.0) 5 (25) 0.053
     IV 0 3 (13) 2 (10) 0.248
     Marijuana 2 (9.55) 6 (26.1) 2 (10) 0.225
Initial CD4 282 274 271 0.873
Initial CV 23.624 (4.31) 12.648 (4.04) 19.467 (4.2) 0.230
Table 4 describes socio-behavioral, clinical and laboratory data by HIV-1 subtype isolated from study participants. 
*Variables with missing data: race n = 95, sexual behavior n = 91, Monthly income n = 89, type of drug (only among users); **Data is presented by total (percentage), 
CD4 initial - median, (interquartil interval), CV initial - median (interquartil interval); log mean ± standard deviation. 
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study and, albeit at a lesser proportion, also in other studies in the south of 
Brazil3,17,19 may suggest some evolutionary advantage for this variant that 
needs to be investigated. The presence of clade C genome in Brazil was 
first documented in Porto Alegre, at a multicentric WHO study in 19928. 
Earlier this decade, an important proportion of clade C was observed in 
Rio Grande city, to the south of our state13.  In 2003 a prevalence of 45% 
of HIV-1 C among patients from the VTS at our public health unit was 
documented, but at the time no discrimination of CRF31_BC and clade C 
was performed4. Although the studies are independent, they may provide 
some insight into the potential growth of clade C in our area. In 2005, 
in another study in the city of Rio Grande, 85 patients were evaluated, 
mostly ARV experimented showing 45% of samples to be clade C, 42% 
clade B, 5% F and 6% recombinants23. In another study, conducted in the 
same year, 108 patients from our VTS showed a prevalence of C genome 
in 58% of cases, with almost half (43%) with the CRF31_BC breakpoint 
pattern at RT17. The presence of such a large proportion of samples with 
a similar breakpoint provided preliminary evidence for a potential new 
CRF. Re-analysis of samples previously registered at NCBI as near full 
length clade C where recognized to actually bear this breakpoint pattern 
at RT. The sequencing of new partial RT along with these reclassified 
near complete genome provides sufficient criteria for the identification 
of a new circulating recombinant form (CRF), numbered 31. Although 
identified in other services in the state and in the neighboring state of 
Santa Catarina3, the proportion observed in our service has never been 
documented elsewhere. This may suggest that the variant originated in 
communities served by our clinical unit. Previous attempts to evaluate the 
putative differential distribution of HIV variants in Brazil have evaluated 
experienced patients20. Our study is the first to evaluate exclusively naïve 
volunteers with HIV in the area, in a public service that harbors a similar 
proportion of individuals with C, B and CRF31_BC HIV variants. By 
removing the bias of treatment impact one may better probe distinctions 
in the populations infected with these variants. Moreover, detailed socio 
behavioral data, including information on certain sexual practices like 
anal sex were evaluated. Although clinical impact may only be assessed 
prospectively, clinical stage at entry may provide some preliminary 
information. At admission, 72.7% were asymptomatic. The median CD4 
count at enrollment was 330.5 cells/mm3. It is noteworthy that this degree 
of immune suppression is moderate compared to the other services in the 
country and even to some services in industrialized countries12. When 
we compare the median CD4 at entry among the distinct variants, our 
patients show comparable counts. The eventual distinct CD4 loss trend 
can only be evaluated with follow up determinations that may also clarify 
potential distinction on the rate of CD4 recovery after HAART. Follow 
up data from this cohort may provide information on clinical outcome 
and possible differential pathogenic potential across different variants. 
The association of risk factors and HIV variants may help to explain 
the dynamics of the epidemic and identify eventual preferential modes of 
transmission of HIV variants21. In 2005, HAART experimented patients 
at another service in Porto Alegre were evaluated and no associations 
were observed, albeit that HIV-1 C was more frequent among women23.
Our study does not confirm these findings, and the proportion of clade 
C among women is only marginally higher. This fact may be related 
to the higher proportion of clade B among gay men, and may be the 
reason why we found a greater proportion of anal sex among clade B 
infected individuals. In fact, other studies suggest a preponderance of 
clade B among men that have sex with men21. It is expected that the 
spread of HIV may benefit from the connectivity within vulnerable 
groups. This might be the case for the gay communities in our area with 
communities in Rio and São Paulo, were clade B predominates4. This 
could be a factor for the dissemination of this HIV subtype among these 
groups1,16. Overall, our socio-behavioral data suggest that the three major 
variants (B, C and CRF31_BC) have similar distribution, without any 
sign of partitioning variants to a particular subpopulation. However, it is 
noteworthy that non-B clade, especially CRF31_BC, is associated with 
exclusive vaginal sex practices. The proportion of females reporting 
anal sex (28%) is similar to that observed in US, were 29.6% of females 
aged 20-24 years report anal sex15. It is known that anal sex represents a 
higher risk of HIV acquisition18. Although the preponderance of subtype 
B among males could be ascribed to its preponderance in the Brazilian 
gay community, our data show a significant association of subtype B and 
anal sex even when only women are analyzed. It is tempting to associate 
non-B clades (subtype C or CRF31_BC) circulating in our area with an 
easier transmission potential, which would accordingly reflect a lesser 
dependence on the more risky anal transmission. This has been suggested 
in other settings but is still an open issue. Our sample size is small and 
further studies are necessary to confirm this hypothesis. Our study 
provides, however, baseline information that may allow the delineation 
of trends of the epidemic in coming years. Continuous surveillance is 
recommended to allow the monitoring of the eventual growth of some 
of these variants in the epidemic. This may be crucial for intervention 
measures and planning of public policies. Determining the eventual 
growth and dominance of clade C may not only help us understand 
the epidemic’s dynamics, but may also contribute to the clarification 
of differences in the pathogenic and transmission potential of HIV 
subtypes, subsidizing vaccines and other innovations in HIV prevention 
and providing pivotal information for the epidemic’s control.
RESUMO
Alta prevalência e associação do subtipo não-B do vírus HIV-1 
com risco específico de transmissão sexual entre pacientes virgens 
de tratamento antirretroviral em Porto Alegre, Brasil
No sul do Brasil a circulação de dois subtipos de HIV-1 com 
características diferentes representa importante cenário para o estudo do 
impacto da diversidade do HIV-1 na evolução da epidemia e na AIDS. O 
HIV-1 B, variante predominante nos países industrializados e o HIV-1 C, 
o subtipo mais prevalente em áreas com maiores taxas de crescimento da 
epidemia, estão implicados na maioria das infecções. Avaliamos amostras 
de sangue de 128 pacientes sem exposição a antirretrovirais, recrutados 
ao ingressarem no maior serviço ambulatorial de HIV/AIDS de Porto 
Alegre. Com base no sequenciamento parcial da região pol, o HIV-1 C 
foi observado em 29%, HIV-1 B em 22,6% e uma forma recombinante 
recentemente descrita, CRF31_BC, foi observada em 23,4% entre 128 
voluntários. Outras variantes encontradas foram HIV-1 F em 10% e 
outros mosaicos em 5,5%. Para avaliar associações entre características 
sócio-comportamentais e subtipos do HIV-1 foram realizadas entrevistas 
e exames laboratoriais na entrada do estudo. Nossos dados sugerem uma 
epidemia estabelecida dessas três variantes principais, sem evidência 
de compartilhamento em nenhum subgrupo analisado. Entretanto, 
prática sexual anal se mostrou associada à transmissão de subtipo B, 
o que pode indicar maior transmissibilidade das variantes não-B por 
intercurso vaginal. Este estudo permite delinear uma linha de base para 
o monitoramento epidemiológico das mudanças nas características 
moleculares da epidemia do HIV-1 nesta região. 
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